{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:20:04Z","timestamp":1792603204059,"version":"4.5.0"},"reference-count":55,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Hepatitis C virus (HCV) infection alters lysophosphatidylcholine (LPC) metabolism, enhancing viral infectivity and replication. Direct-acting antivirals (DAAs) effectively treat HCV and rapidly normalize serum cholesterol. In serum, LPC species are primarily albumin-bound but are also present in lipoprotein particles. This study aims to assess the impact of HCV eradication on serum LPC species levels in patients infected with HCV. Therefore, 12 different LPC species were measured by electrospray ionization tandem mass spectrometry (ESI-MS\/MS) in the sera of 178 patients with chronic HCV infections at baseline, and in 176 of these patients after therapy with DAAs. All LPC species increased at 4 and 12 weeks post-initiation of DAA therapy. The serum profiles of the LPC species were similar before and after the viral cure. Patients with HCV and liver cirrhosis exhibited lower serum levels of all LPC species, except LPC 16:1, both before and after DAA treatment. Percentages of LPC 18:1 (relative to the total LPC level) were higher, and % LPC 22:5 and 22:6 were lower in cirrhotic compared to non-cirrhotic patients at baseline and at the end of therapy. LPC species levels inversely correlated with the model of end-stage liver disease score and directly with baseline and post-therapy albumin levels. Receiver operating characteristic curve analysis indicated an area under the curve of 0.773 and 0.720 for % LPC 18:1 (relative to total LPC levels) for classifying fibrosis at baseline and post-therapy, respectively. In summary, HCV elimination was found to increase all LPC species and elevated LPC 18:1 relative to total LPC levels may have pathological significance in HCV-related liver cirrhosis.<\/jats:p>","DOI":"10.3390\/ijms25021198","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T11:28:46Z","timestamp":1705577326000},"page":"1198","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Rising Lysophosphatidylcholine Levels Post-Hepatitis C Clearance"],"prefix":"10.3390","volume":"25","author":[{"given":"Georg","family":"Peschel","sequence":"first","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany"},{"name":"Department of Internal Medicine, Klinikum F\u00fcrstenfeldbruck, 82256 F\u00fcrstenfeldbruck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Krautbauer","sequence":"additional","affiliation":[{"name":"Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kilian","family":"Weigand","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany"},{"name":"Department of Gastroenterology, Gemeinschaftsklinikum Mittelrhein, 56073 Koblenz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Grimm","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"H\u00f6ring","sequence":"additional","affiliation":[{"name":"Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Liebisch","sequence":"additional","affiliation":[{"name":"Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5635-3994","authenticated-orcid":false,"given":"Christa","family":"Buechler","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/hep.20030","article-title":"Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth","volume":"39","author":"Casiraghi","year":"2004","journal-title":"Hepatology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.3748\/wjg.v22.i6.1953","article-title":"Hepatitis C virus relies on lipoproteins for its life cycle","volume":"22","author":"Grassi","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Sidorkiewicz, M. (2021). Hepatitis C Virus Uses Host Lipids to Its Own Advantage. Metabolites, 11.","DOI":"10.3390\/metabo11050273"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","article-title":"EASL recommendations on treatment of hepatitis C: Final update of the series","volume":"73","author":"Pawlotsky","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.3748\/wjg.v23.i13.2355","article-title":"Impact of interferon-free antivirus therapy on lipid profiles in patients with chronic hepatitis C genotype 1b","volume":"23","author":"Endo","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Hashimoto, S., Yatsuhashi, H., Abiru, S., Yamasaki, K., Komori, A., Nagaoka, S., Saeki, A., Uchida, S., Bekki, S., and Kugiyama, Y. (2016). Rapid Increase in Serum Low-Density Lipoprotein Cholesterol Concentration during Hepatitis C Interferon-Free Treatment. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0163644"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Peschel, G., Grimm, J., Gulow, K., Muller, M., Buechler, C., and Weigand, K. (2020). Chemerin Is a Valuable Biomarker in Patients with HCV Infection and Correlates with Liver Injury. Diagnostics, 10.","DOI":"10.3390\/diagnostics10110974"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"13944","DOI":"10.1038\/s41598-021-93251-3","article-title":"Serum lipid profile in HCV patients treated with direct-acting antivirals: A systematic review and meta-analysis","volume":"11","author":"Villani","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1194\/jlr.D800028-JLR200","article-title":"Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry","volume":"50","author":"Wiesner","year":"2009","journal-title":"J. Lipid Res."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Law, S.H., Chan, M.L., Marathe, G.K., Parveen, F., Chen, C.H., and Ke, L.Y. (2019). An Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20051149"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1136\/gutjnl-2016-311508","article-title":"Lysophosphatidylcholine acyltransferase 1 is downregulated by hepatitis C virus: Impact on production of lipo-viro-particles","volume":"66","author":"Beilstein","year":"2017","journal-title":"Gut"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jhep.2017.01.009","article-title":"Autotaxin-lysophosphatidic acid receptor signalling regulates hepatitis C virus replication","volume":"66","author":"Farquhar","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"39436","DOI":"10.1074\/jbc.M205623200","article-title":"Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase","volume":"277","author":"Tokumura","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Kostadinova, L., Shive, C.L., and Anthony, D.D. (2019). Elevated Autotaxin and LPA Levels During Chronic Viral Hepatitis and Hepatocellular Carcinoma Associate with Systemic Immune Activation. Cancers, 11.","DOI":"10.3390\/cancers11121867"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/infdis\/jiw372","article-title":"During Hepatitis C Virus (HCV) Infection and HCV-HIV Coinfection, an Elevated Plasma Level of Autotaxin Is Associated with Lysophosphatidic Acid and Markers of Immune Activation That Normalize during Interferon-Free HCV Therapy","volume":"214","author":"Kostadinova","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/jgh.15114","article-title":"Association of serum autotaxin levels with liver fibrosis in patients pretreatment and posttreatment with chronic hepatitis C","volume":"36","author":"Takemura","year":"2021","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Yamazaki, T., Joshita, S., Umemura, T., Usami, Y., Sugiura, A., Fujimori, N., Kimura, T., Matsumoto, A., Igarashi, K., and Ota, M. (2018). Changes in serum levels of autotaxin with direct-acting antiviral therapy in patients with chronic hepatitis C. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0195632"},{"key":"ref_18","first-page":"285","article-title":"The relationship between lipid profile and severity of liver damage in cirrhotic patients","volume":"10","author":"Ghadir","year":"2010","journal-title":"Hepat. Mon."},{"key":"ref_19","first-page":"OC15","article-title":"Association of Serum Lipids with Hepatic Steatosis, Stage of Liver Fibrosis and Viral Load in Chronic Hepatitis C","volume":"11","author":"Valkov","year":"2017","journal-title":"J. Clin. Diagn. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1159\/000339206","article-title":"Lipid serum profile in patients with viral liver cirrhosis","volume":"21","author":"Vere","year":"2012","journal-title":"Med. Princ. Pract."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"100708","DOI":"10.1016\/j.aohep.2022.100708","article-title":"Position statement on the use of albumin in liver cirrhosis","volume":"27","author":"Bosques","year":"2022","journal-title":"Ann. Hepatol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Horing, M., Peschel, G., Grimm, J., Krautbauer, S., Muller, M., Weigand, K., Liebisch, G., and Buechler, C. (2022). Serum Ceramide Species Are Associated with Liver Cirrhosis and Viral Genotype in Patients with Hepatitis C Infection. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23179806"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1111\/liv.14580","article-title":"Plasma metabolomic fingerprint of advanced cirrhosis stages among HIV\/HCV-coinfected and HCV-monoinfected patients","volume":"40","author":"Salguero","year":"2020","journal-title":"Liver Int."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1021\/pr300683a","article-title":"Serum metabolic profiling study of hepatocellular carcinoma infected with hepatitis B or hepatitis C virus by using liquid chromatography-mass spectrometry","volume":"11","author":"Zhou","year":"2012","journal-title":"J. Proteome Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1073\/pnas.91.3.1069","article-title":"Lysophosphatidylcholine upregulates the level of heparin-binding epidermal growth factor-like growth factor mRNA in human monocytes","volume":"91","author":"Nakano","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Heimerl, S., Fischer, M., Baessler, A., Liebisch, G., Sigruener, A., Wallner, S., and Schmitz, G. (2014). Alterations of plasma lysophosphatidylcholine species in obesity and weight loss. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0111348"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Buechler, C., and Aslanidis, C. (2020). Role of lipids in pathophysiology, diagnosis and therapy of hepatocellular carcinoma. Biochim. Biophys. Acta Mol. Cell Biol. Lipids, 1865.","DOI":"10.1016\/j.bbalip.2020.158658"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest","volume":"46","author":"Mallet","year":"2007","journal-title":"Hepatology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1097\/JTO.0b013e3181ec173d","article-title":"Receiver operating characteristic curve in diagnostic test assessment","volume":"5","author":"Mandrekar","year":"2010","journal-title":"J. Thorac. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"100479","DOI":"10.1016\/j.jhepr.2022.100479","article-title":"Lipid alterations in chronic liver disease and liver cancer","volume":"4","author":"Paul","year":"2022","journal-title":"JHEP Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s13337-020-00592-0","article-title":"HCV genotypes and their determinative role in hepatitis C treatment","volume":"31","author":"Keikha","year":"2020","journal-title":"Virusdisease"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.1038\/s41598-022-09588-w","article-title":"Infection with the hepatitis C virus causes viral genotype-specific differences in cholesterol metabolism and hepatic steatosis","volume":"12","author":"Sheridan","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s43066-021-00110-x","article-title":"The effect of hepatitis C virologic clearance on cardiovascular disease biomarker lipoprotein-associated phospholipase A2 and its relation to serum lipids","volume":"11","author":"Isaac","year":"2021","journal-title":"Egypt. Liver J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1388-1981(00)00153-0","article-title":"Lecithin cholesterol acyltransferase","volume":"1529","author":"Jonas","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_35","first-page":"85","article-title":"The etiology, diagnosis and prevention of liver cirrhosis: Part 1 of a series on liver cirrhosis","volume":"110","author":"Wiegand","year":"2013","journal-title":"Dtsch. Arztebl. Int."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Buechler, C., Haberl, E.M., Rein-Fischboeck, L., and Aslanidis, C. (2017). Adipokines in Liver Cirrhosis. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18071392"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1172\/JCI88881","article-title":"Liver inflammation and fibrosis","volume":"127","author":"Koyama","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_38","first-page":"1","article-title":"Triglyceride Metabolism in the Liver","volume":"8","author":"Cohen","year":"2017","journal-title":"Compr. Physiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00216-012-5782-4","article-title":"Serum metabolomics reveals the deregulation of fatty acids metabolism in hepatocellular carcinoma and chronic liver diseases","volume":"403","author":"Zhou","year":"2012","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"100477","DOI":"10.1016\/j.jhepr.2022.100477","article-title":"Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease","volume":"4","author":"McGlinchey","year":"2022","journal-title":"JHEP Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.metabol.2017.08.014","article-title":"Lipidome as a predictive tool in progression to type 2 diabetes in Finnish men","volume":"78","author":"Suvitaival","year":"2018","journal-title":"Metabolism"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"677202","DOI":"10.3389\/fendo.2022.677202","article-title":"The Changes of Lipidomic Profiles Reveal Therapeutic Effects of Exenatide in Patients With Type 2 Diabetes","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Barber, M.N., Risis, S., Yang, C., Meikle, P.J., Staples, M., Febbraio, M.A., and Bruce, C.R. (2012). Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0041456"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12986-018-0288-5","article-title":"Changes in lysophospholipids and liver status after weight loss: The RESMENA study","volume":"15","author":"Cantero","year":"2018","journal-title":"Nutr. Metab."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Rau, M., Buggisch, P., Mauss, S., Boeker, K.H.W., Klinker, H., Muller, T., Stoehr, A., Schattenberg, J.M., and Geier, A. (2022). Prognostic impact of steatosis in the clinical course of chronic HCV infection-Results from the German Hepatitis C-Registry. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0264741"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3233\/CH-211193","article-title":"Liver stiffness assessed by shear-wave elastography declines in parallel with immunoregulatory proteins in patients with chronic HCV infection during DAA therapy","volume":"79","author":"Peschel","year":"2021","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Schmedes, M., Balderas, C., Aadland, E.K., Jacques, H., Lavigne, C., Graff, I.E., Eng, O., Holthe, A., Mellgren, G., and Young, J.F. (2018). The Effect of Lean-Seafood and Non-Seafood Diets on Fasting and Postprandial Serum Metabolites and Lipid Species: Results from a Randomized Crossover Intervention Study in Healthy Adults. Nutrients, 10.","DOI":"10.3390\/nu10050598"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/hep.25653","article-title":"Review and management of drug interactions with boceprevir and telaprevir","volume":"55","author":"Kiser","year":"2012","journal-title":"Hepatology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e16270","DOI":"10.1097\/MD.0000000000016270","article-title":"Ultrasound is highly specific in diagnosing compensated cirrhosis in chronic hepatitis C patients in real world clinical practice","volume":"98","author":"Yen","year":"2019","journal-title":"Medicine"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/ajg.2016.453","article-title":"Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis","volume":"112","author":"McPherson","year":"2017","journal-title":"Am. J. Gastroenterol."},{"key":"ref_51","first-page":"29","article-title":"Quantification of lysophosphatidylcholine species by high-throughput electrospray ionization tandem mass spectrometry (ESI-MS\/MS)","volume":"580","author":"Liebisch","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/y59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can. J. Biochem. Physiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bbalip.2004.09.003","article-title":"High-throughput quantification of phosphatidylcholine and sphingomyelin by electrospray ionization tandem mass spectrometry coupled with isotope correction algorithm","volume":"1686","author":"Liebisch","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1073274817729235","DOI":"10.1177\/1073274817729235","article-title":"Staging and Prognostic Models for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma","volume":"24","author":"Burkhart","year":"2017","journal-title":"Cancer Control"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/2\/1198\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:49:58Z","timestamp":1760104198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/2\/1198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,18]]},"references-count":55,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["ijms25021198"],"URL":"https:\/\/doi.org\/10.3390\/ijms25021198","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,18]]}}}